SCHEMBL19959780

SCHEMBL19959780

O=P(c1ccncc1)(c1ccc2cccnc2c1)c1cccc2c1nc1c3ccccc3c3ccccc3n21

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19959778 0.89
SCHEMBL19959792 0.89 KDM4E (0.31) KDM4ELMNAPOLB
SCHEMBL19959819 0.88 SLC40A1 (0.34)
SCHEMBL19959785 0.86 CYP3A4 (0.32) KDM4ELMNAPOLB
SCHEMBL19959788 0.86 CYP3A4 (0.35) KDM4ELMNAPOLB
SCHEMBL19959797 0.85 BCL2 (0.31) KDM4ELMNAPOLB
SCHEMBL19959822 0.85 BCL2 (0.35) KDM4ELMNAPOLB
SCHEMBL19959805 0.83 KDM4E (0.34) KDM4ELMNAPOLB
SCHEMBL19959838 0.83 KDM4E (0.34) KDM4ELMNAPOLB
SCHEMBL19959810 0.82 KDM4E (0.34) KDM4ELMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-06-30 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 KDM4E 1997/4885LMNA 3023/4885POLB 2517/4885
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 KDM4E 1997/4885LMNA 3023/4885POLB 2517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.